Browsing by Author Borg, John Joseph
Showing results 1 to 6 of 6
| Issue Date | Title | Author(s) |
| 2022 | The changing landscape of treatment options in childhood acute lymphoblastic leukaemia | Micallef, Benjamin; Nisticò, Robert; Sarac, Sinan B.; Bjerrum, Ole W.; Butler, Dianne; Sammut Bartolo, Nicolette; Serracino-Inglott, Anthony; Borg, John Joseph |
| 1997-10-23 | "Fef fodz fumz, i zmell the zmell of an irdizman!" | Borg, John Joseph |
| 2014 | Licensing of generic medicines : are there any challenges left? A pharmaceutical regulatory perspective | Borg, John Joseph; Tomasi, Paolo; Pani, Luca; Aislaitner, George; Pirozynski, Michal; Leufkens, Hubert; Melchiorri, Daniela |
| 2022 | Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia | Micallef, Benjamin; Nistico, Robert; Bjerrum, Ole Weis; Sarac, Sinan Bardakci; Butler, Dianne; Serracino-Inglott, Anthony; Borg, John Joseph |
| 2014 | Reflections on decisions made on the well-established use of medicinal products by EU regulators and the ECJ | Borg, John Joseph; Laslop, Andrea; Pani, Luca; Maciulaitis, Romaldas; Melchiorri, Daniela |
| 2009 | Where is industry getting it wrong? A review of quality concerns raised at day 120 by the Committee for Medicinal Products for Human Use during European centralised marketing authorisation submissions for chemical entity medicinal products | Borg, John Joseph; Robert, Jean-Louis; Wade, George; Aislaitner, George; Pirożynski, Michal; Abadie, Eric; Salmonson, Tomas; Vella Bonanno, Patricia |
